% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Heesen:278645,
author = {P. Heesen and A. Ranft and V. Bhadri and B. Brichard and S.
Collaud and S. Cyprova and H. Eich and T. Ek and H.
Gelderblom and J. Hardes and L. Haveman and S. Jabar and W.
Hartmann and D. Andreou and P. Hauser and J. Kersting and H.
Juergens and J. Kanerva and T. Kühne and A. Raciborska and
J. Rascon and A. Streitbürger and B. Timmermann$^*$ and Y.
Uhlenbruch and U. Dirksen},
title = {{A}ssociation between local treatment modalities and
event-free survival, overall survival, and local recurrence
in patients with localised {E}wing {S}arcoma. {R}eport from
the {E}wing 2008 trial.},
journal = {European journal of cancer},
volume = {192},
issn = {0014-2964},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2023-01689},
pages = {113260},
year = {2023},
abstract = {Local treatment is a crucial element in the standard of
care for Ewing sarcoma (EWS). While systemic treatment is
improved in randomised clinical trials, local treatment
modalities are discussed controversially. We analysed the
association between local therapy and event-free survival
(EFS), overall survival (OS), and local recurrence (LR) in
prospectively collected data of patients with localised
EWS.We analysed data from the international Ewing 2008 study
registered between 2009 and 2019 in 117 centres. After
induction chemotherapy, patients received surgery,
radiotherapy, or a combination thereof. We performed Cox
regression, conducted propensity score-weighted sensitivity
analysis, and performed subgroup analyses. Hazard ratios
(HRs) and $95\%$ confidence intervals are reported.We
included 863 patients with localised EWS (surgery alone:
331, combination therapy: 358, definitive radiotherapy:
174). In patients treated with combination therapy compared
to surgery alone, EFS HR was 0.84 (0.57-1.24; p = 0.38), OS
HR was 0.84 (0.57-1.23; p = 0.41), and LR HR was 0.58
(0.26-1.31; p = 0.19). Hazards of any event were increased
in patients treated with definitive radiotherapy compared to
surgery only, HR 1.53 (1.02-2.31; p = 0.04). Patients with
poor responses to chemotherapy benefitted from combination
therapy over definitive surgery with an EFS HR 0.49
(0.27-0.89; p = 0.02). Patients with pelvic tumours
benefitted from combination therapy over surgery only
regarding LR, HR 0.12 (0.02-0.72; p = 0.02).Patients with
poor responses to chemotherapy benefitted from radiotherapy
added to surgery. In the whole group, radiotherapy alone as
opposed to surgery alone increased the hazards of any
event.},
keywords = {Bone tumour (Other) / Ewing sarcoma (Other) / Local therapy
(Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37595489},
doi = {10.1016/j.ejca.2023.113260},
url = {https://inrepo02.dkfz.de/record/278645},
}